Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
12.72
+0.52 (4.26%)
At close: Apr 28, 2025, 4:00 PM
12.72
0.00 (0.00%)
After-hours: Apr 28, 2025, 5:00 PM EDT
Organon & Co. Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Organon & Co. stock have an average target of 20.6, with a low estimate of 15 and a high estimate of 24. The average target predicts an increase of 61.95% from the current stock price of 12.72.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Organon & Co. stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +17.92% | Apr 9, 2025 |
Barclays | Barclays | Buy Maintains $26 → $24 | Buy | Maintains | $26 → $24 | +88.68% | Feb 14, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $16 | Hold | Maintains | $17 → $16 | +25.79% | Feb 14, 2025 |
JP Morgan | JP Morgan | Hold → Sell Downgrades $18 → $20 | Hold → Sell | Downgrades | $18 → $20 | +57.23% | Sep 6, 2024 |
Goldman Sachs | Goldman Sachs | Hold Maintains $18 → $20 | Hold | Maintains | $18 → $20 | +57.23% | May 6, 2024 |
Financial Forecast
Revenue This Year
6.29B
from 6.40B
Decreased by -1.81%
Revenue Next Year
6.34B
from 6.29B
Increased by 0.91%
EPS This Year
3.81
from 3.33
Increased by 14.35%
EPS Next Year
4.03
from 3.81
Increased by 5.94%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 6.6B | 6.7B | 6.8B | ||
Avg | 6.3B | 6.3B | 6.4B | ||
Low | 6.0B | 6.0B | 6.0B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 3.0% | 6.6% | 6.8% | ||
Avg | -1.8% | 0.9% | 1.0% | ||
Low | -5.7% | -4.2% | -4.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.05 | 4.55 | 4.52 | ||
Avg | 3.81 | 4.03 | 4.13 | ||
Low | 3.59 | 3.63 | 3.71 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 21.7% | 19.4% | 11.9% | ||
Avg | 14.3% | 5.9% | 2.4% | ||
Low | 7.7% | -4.8% | -7.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.